Recognizing the distinction between the two types of claims could have helped avoid the high number of “unnecessary” claims rejections.
Following the European Food Safety Authority’s (EFSA; Parma, Italy) third batch of Article 13.1 health claims opinions released in January, three groups are arguing that EFSA should distinguish whether, during its scientific assessment of proposed health claims, it evaluated claims for “health function maintenance” or for “health function improvement.”
According to the groups, considering that sufficient data may not be available to support a “maintenance” claim, both types of claims should be recognized. “A clear distinction would enable claims of different strengths to coexist on the EU market,” said the European Federation of Associations of Health Product Manufacturers (EHPM), which jointly filed comments together with the European Responsible Nutrition Alliance (ERNA) and the European Botanical Forum. They added that recognizing the distinction between the two types of claims could have helped avoid the high number of “unnecessary” claims rejections.
“We…believe that a number of claims for which evidence is available are now close to rejection because of the approach taken,” said ERNA’s chair Catherine Mignot, in a press statement.
Read more here.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.